InvestorsHub Logo
Followers 230
Posts 21496
Boards Moderated 2
Alias Born 08/03/2006

Re: None

Wednesday, 08/24/2022 10:36:28 AM

Wednesday, August 24, 2022 10:36:28 AM

Post# of 404
Just some FYI...

https://finviz.com/quote.ashx?t=BXRX&p=m&tas=0

Float 6.03M.

Aug 23 Presentation
https://d1io3yog0oux5.cloudfront.net/_901ee2762ab0a9fe74fbbb597524e7cc/baudaxbio/db/227/1543/pdf/BXRX+August+Corporate+Presentation.8.23.22.Final.pdf
https://www.baudaxbio.com/news-and-investors/presentations

Two novel NMBs & a novel reversal agent in development

•Neuromuscular blocking agents–BX1000: Intermediate acting agent duration of action (~45 mins*)
•Rapid onset•Completed one Dose escalation clinical trial; Phase 2 surgical trial expected to commence in 2022

–BX2000: Ultra-short acting agent duration of action (10-15 mins*)
•Rapid onset
•Dosing completed for the second cohort of Phase 1 clinical study evaluating the safety,tolerability and pharmacokinetics in healthy volunteers
•Novel reversal agent

–Specific for BX1000 and BX2000; provides complete chemical reversal ofneuromuscular blockade from any depth of block within 2-5 minutes*
•In pre-clinical development; expect to file IND in the first half of 2023


burn rate was reduced by approximately 65% going forward

On the technical side bottom may be getting closer. Though a lower low is still a lower low, it MAY be worth the risk for a piece.

IMO of course.

And yes, I do own shares of BXRX.


Do your research! Play the TA. All posts are my opinion.
Is fundamental trading dead?

"We hope not." Richard Dennis